Figure 2

Improvements in glycemic control over 104 weeks in the completer population (N = 216) and intent-to-treat population (N = 295). A) LS mean ± SE changes in A1C over 104 weeks. Baseline (BL) was 8.2% in the 2-year completer population and 8.3% in the ITT population. B) Proportion of patients who achieved A1C targets of <7.0%, ≤6.5%, and ≤6.0%. C) LS mean ± SE changes in fasting plasma glucose over 104 weeks. Baseline was 168 mg/dL in the 2-year completer population and 169 mg/dL in the ITT population.